Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Sharing with Strangers: Governance Models for Borderless Genomic Research in a Territorial World.

Juengst ET, Meslin EM.

Kennedy Inst Ethics J. 2019;29(1):67-95. doi: 10.1353/ken.2019.0000.

PMID:
31080178
2.

In Honor of LeRoy Walters: Introduction from the Editors.

Meslin EM, Juengst ET, Spicer CM.

Kennedy Inst Ethics J. 2019;29(1):xi-xvi. doi: 10.1353/ken.2019.0007. No abstract available.

PMID:
31080174
3.

Is Enhancement the Price of Prevention in Human Gene Editing?

Juengst ET, Henderson GE, Walker RL, Conley JM, MacKay D, Meagher KM, Saylor K, Waltz M, Kuczynski KJ, Cadigan RJ.

CRISPR J. 2018 Dec;1:351-354. doi: 10.1089/crispr.2018.0040. Epub 2018 Nov 26.

4.

Why Does the Shift from "Personalized Medicine" to "Precision Health" and "Wellness Genomics" Matter?

Juengst ET, McGowan ML.

AMA J Ethics. 2018 Sep 1;20(9):E881-890. doi: 10.1001/amajethics.2018.881.

5.

Grudging Trust and the Limits of Trustworthy Biorepository Curation.

Meagher KM, Juengst ET, Henderson GE.

Am J Bioeth. 2018 Apr;18(4):23-25. doi: 10.1080/15265161.2018.1431329. No abstract available.

6.

Crowdsourcing the Moral Limits of Human Gene Editing?

Juengst ET.

Hastings Cent Rep. 2017 May;47(3):15-23. doi: 10.1002/hast.701.

PMID:
28543411
7.

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention.

Meagher KM, McGowan ML, Settersten RA Jr, Fishman JR, Juengst ET.

Annu Rev Genomics Hum Genet. 2017 Aug 31;18:369-387. doi: 10.1146/annurev-genom-091416-035222. Epub 2017 Apr 24. Review.

8.

Citizen science or scientific citizenship? Disentangling the uses of public engagement rhetoric in national research initiatives.

Woolley JP, McGowan ML, Teare HJ, Coathup V, Fishman JR, Settersten RA Jr, Sterckx S, Kaye J, Juengst ET.

BMC Med Ethics. 2016 Jun 4;17(1):33. doi: 10.1186/s12910-016-0117-1.

9.

Response to Open Peer Commentaries on "Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice".

Lázaro-Muñoz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET.

Am J Bioeth. 2015;15(12):W6-9. doi: 10.1080/15265161.2015.1096069. No abstract available.

PMID:
26632375
10.

CHALLENGES FOR IMPLEMENTING A PTSD PREVENTIVE GENOMIC SEQUENCING PROGRAM IN THE U.S. MILITARY.

Lázaro-Muñoz G, Juengst ET.

Case West Reserve J Int Law. 2015 Spring;47(1):87-113.

11.

A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.

Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, Strande NT, Weck KE, Wilhelmsen KC, Evans JP.

Genet Med. 2016 May;18(5):467-75. doi: 10.1038/gim.2015.104. Epub 2015 Aug 13.

12.

Looking for Trouble: Preventive Genomic Sequencing in the General Population and the Role of Patient Choice.

Lázaro-Muñoz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET.

Am J Bioeth. 2015;15(7):3-14. doi: 10.1080/15265161.2015.1039721.

13.

Gatekeepers or intermediaries? The role of clinicians in commercial genomic testing.

McGowan ML, Fishman JR, Settersten RA Jr, Lambrix MA, Juengst ET.

PLoS One. 2014 Sep 26;9(9):e108484. doi: 10.1371/journal.pone.0108484. eCollection 2014.

14.

Serving epigenetics before its time.

Juengst ET, Fishman JR, McGowan ML, Settersten RA Jr.

Trends Genet. 2014 Oct;30(10):427-9. doi: 10.1016/j.tig.2014.08.001.

PMID:
25242336
15.

Genomic research with the newly dead: a crossroads for ethics and policy.

Walker RL, Juengst ET, Whipple W, Davis AM.

J Law Med Ethics. 2014 Summer;42(2):220-31. doi: 10.1111/jlme.12137.

16.

Big data, open science and the brain: lessons learned from genomics.

Choudhury S, Fishman JR, McGowan ML, Juengst ET.

Front Hum Neurosci. 2014 May 16;8:239. doi: 10.3389/fnhum.2014.00239. eCollection 2014. Review.

17.
18.

Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.

McGowan ML, Settersten RA Jr, Juengst ET, Fishman JR.

Urol Oncol. 2014 Feb;32(2):187-92. doi: 10.1016/j.urolonc.2013.10.009.

19.

After the revolution? Ethical and social challenges in 'personalized genomic medicine'

Juengst ET, Settersten RA Jr, Fishman JR, McGowan ML.

Per Med. 2012 Jun 1;9(4):429-439.

20.

What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011.

Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M.

J Law Med Ethics. 2012 Winter;40(4):1008-24. doi: 10.1111/j.1748-720X.2012.00728.x.

21.

Personalized genomic medicine and the rhetoric of empowerment.

Juengst ET, Flatt MA, Settersten RA Jr.

Hastings Cent Rep. 2012 Sep-Oct;42(5):34-40. doi: 10.1002/hast.65. No abstract available.

22.

Research priorities. ELSI 2.0 for genomics and society.

Kaye J, Meslin EM, Knoppers BM, Juengst ET, Deschênes M, Cambon-Thomsen A, Chalmers D, De Vries J, Edwards K, Hoppe N, Kent A, Adebamowo C, Marshall P, Kato K.

Science. 2012 May 11;336(6082):673-4. doi: 10.1126/science.1218015. No abstract available.

23.

Ethical and legal issues in enhancement research on human subjects.

Mehlman MJ, Berg JW, Juengst ET, Kodish E.

Camb Q Healthc Ethics. 2011 Jan;20(1):30-45. doi: 10.1017/S0963180110000605. No abstract available.

PMID:
21223608
24.

The ethics of using transgenic non-human primates to study what makes us human.

Coors ME, Glover JJ, Juengst ET, Sikela JM.

Nat Rev Genet. 2010 Sep;11(9):658-62. doi: 10.1038/nrg2864. Review.

25.

GINA and preemployment criminal background checks.

Callier SL, Huss J, Juengst ET.

Hastings Cent Rep. 2010 Jan-Feb;40(1):15-9. No abstract available.

26.

Origin myths in Bioethics: constructing sources, motives and reason in Bioethic(s).

Gaines AD, Juengst ET.

Cult Med Psychiatry. 2008 Sep;32(3):303-27. doi: 10.1007/s11013-008-9105-3.

PMID:
18574678
27.

Research ethics recommendations for whole-genome research: consensus statement.

Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray PN, Sugarman J, Timmons M.

PLoS Biol. 2008 Mar 25;6(3):e73. doi: 10.1371/journal.pbio.0060073. No abstract available.

28.

Boundaries and labels: anti-aging medicine and science.

Binstock RH, Fishman JR, Juengst ET.

Rejuvenation Res. 2006 Winter;9(4):433-5. No abstract available.

PMID:
17105380
29.

Thresholds and boundaries in the disclosure of individual genetic research results.

Dressler LG, Juengst ET.

Am J Bioeth. 2006 Nov-Dec;6(6):18-20; author reply W10-2. No abstract available.

PMID:
17085396
30.

Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics.

Whitehouse PJ, Juengst ET.

J Am Geriatr Soc. 2005 Aug;53(8):1417-22. Review.

PMID:
16078972
31.

I-DNA-fication, personal privacy, and social justice.

Juengst ET.

Chic Kent Law Rev. 1999;75:61-82. No abstract available.

PMID:
15732203
32.

Genetic enhancement.

McGee G, Juengst ET.

Med Ethics (Burlingt Mass). 1999 Fall:6-7. No abstract available.

PMID:
15584182
33.

Ethical issues in identifying and recruiting participants for familial genetic research.

Beskow LM, Botkin JR, Daly M, Juengst ET, Lehmann LS, Merz JF, Pentz R, Press NA, Ross LF, Sugarman J, Susswein LR, Terry SF, Austin MA, Burke W.

Am J Med Genet A. 2004 Nov 1;130A(4):424-31.

PMID:
15455364
34.

FACE facts: why human genetics will always provoke bioethics.

Juengst ET.

J Law Med Ethics. 2004 Summer;32(2):267-75, 191.

PMID:
15301191
35.

Anti-aging medicine: can consumers be better protected?

Mehlman MJ, Binstock RH, Juengst ET, Ponsaran RS, Whitehouse PJ.

Gerontologist. 2004 Jun;44(3):304-10. Review.

PMID:
15197284
36.

Extraordinary litmus tests.

Binstock RH, Juengst ET, Mehlman MJ, Post SG.

Hastings Cent Rep. 2004 Mar-Apr;34(2):4; author reply 4-5. No abstract available.

PMID:
15156827
37.

Biogerontology, "anti-aging medicine," and the challenges of human enhancement.

Juengst ET, Binstock RH, Mehlman M, Post SG, Whitehouse P.

Hastings Cent Rep. 2003 Jul-Aug;33(4):21-30. No abstract available.

PMID:
12971058
38.
39.

Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience.

Dugan RB, Wiesner GL, Juengst ET, O'Riordan M, Matthews AL, Robin NH.

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):27-34.

PMID:
12704635
40.

Aging. Antiaging research and the need for public dialogue.

Juengst ET, Binstock RH, Mehlman MJ, Post SG.

Science. 2003 Feb 28;299(5611):1323. No abstract available.

PMID:
12610284
41.
42.

Gene-poor vermin: humanity's new place in nature.

Juengst ET.

Hastings Cent Rep. 2001 Mar-Apr;31(2):7. No abstract available.

PMID:
11478115
43.

Commentary: what "community review" can and cannot do.

Juengst ET.

J Law Med Ethics. 2000 Spring;28(1):52-4, 3.

PMID:
11067633
44.

Group identity and human diversity: keeping biology straight from culture.

Juengst ET.

Am J Hum Genet. 1998 Sep;63(3):673-7. No abstract available.

45.

Can enhancement be distinguished from prevention in genetic medicine?

Juengst ET.

J Med Philos. 1997 Apr;22(2):125-42.

PMID:
9186925
46.

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.

Post SG, Whitehouse PJ, Binstock RH, Bird TD, Eckert SK, Farrer LA, Fleck LM, Gaines AD, Juengst ET, Karlinsky H, Miles S, Murray TH, Quaid KA, Relkin NR, Roses AD, St George-Hyslop PH, Sachs GA, Steinbock B, Truschke EF, Zinn AB.

JAMA. 1997 Mar 12;277(10):832-6. Review.

PMID:
9052715
47.
48.

Self-critical federal science? The ethics experiment within the U.S. Human Genome Project.

Juengst ET.

Soc Philos Policy. 1996 Summer;13(2):63-95. No abstract available.

PMID:
11653300
49.

"Prevention" and the goals of genetic medicine.

Juengst ET.

Hum Gene Ther. 1995 Dec;6(12):1595-605.

PMID:
8664384
50.

Ethics of prediction: genetic risk and the physician-patient relationship.

Juengst ET.

Genome Sci Technol. 1995;1(1):21-36. No abstract available.

PMID:
11660453

Supplemental Content

Loading ...
Support Center